US OptionsDetailed Quotes
QTTB241220C25000
- 0.05
- 0.000.00%
15min DelayClose Dec 20 16:00 ET
0.00High0.00Low
0.00Open0.05Pre Close0 Volume133 Open Interest25.00Strike Price0.00Turnover0.00%IV584.43%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier-17DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma73.20Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Q32 Bio Stock Discussion
$Q32 Bio (QTTB.US)$ reverse trend? get it before it's talked about, after a 50 percent gain day.... 22 percent shorts float.... they had some horrible news on december 11th. did there dip. most analysts have downgraded targets from $40-$50 down to $10-$20. which is still considerably higher than $4. looks to have consolidated around the 3-4. breaking the downward trend. I will be buying before the burst this week.... low shares low float. ... risky business is the name of the...
Worse than placebo for Eczema, ouch
Alopecia worked well, but probably people were looking for the eczema market?
Sorry I am sleepy cant finish the list.
$Rigetti Computing (RGTI.US)$ PR today 12/10: Quantum Machines And Rigetti Computing Announces The Application Of AI To Automate The Calibration Of A Quantum Computer. Up after hours. SI 13.89%, 0 shares LTB✅
$SEALSQ Corp (LAES.US)$ PR 12/10: Partnership with IC’ALPS to ...
Q32 Bio Provides Bempikibart Program Update, Including Next Steps for Advancing Alopecia Areata Development Program
Tuesday, 10th December at 4:05 pm
-- SIGNAL-AA demonstrated encouraging clinical activity of bempikibart in patients with alopecia areata (AA), including improvement from baseline on SALT score and meaningful achievement of SALT-20 response --
-- SIGNAL-AD Phase 2a clinical trial in atopic dermatitis demonstrated promising findings in Part A but did not meet ...
No comment yet